Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
5
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
bristol-myers squibb
clinical trials
nonalcoholic steatohepatitis
affordable care act
cancer immunotherapy
deals
fda
johnson & johnson
merck
startups
abbvie
abeona therapeutics
aducanumab
What
nash
5
×
roundup
5
×
bio
news
drug
biogen’s
companies
disease
according
aducanumab
akcea
alzheimer’s
american
amyloid
angst
approval
approved
bagged
based
best
billions
biogen
biopharmaceutical
biotech
brammer
cases
centers
cigarettes
continue
control
convo
crash
deaths
debate
digital
earlier
effects
electronic
epidemic
failure
Language
unset
Current search:
roundup
×
nash
×
" life sciences "
×
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More